Navigation Links
Zimmer Announces Expiration of Deferred Prosecution Agreement

WARSAW, Ind., March 30 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH), a leader in the orthopaedic industry, today announced that the Deferred Prosecution Agreement (DPA) with the United States Attorney's Office for the District of New Jersey had expired as scheduled. The Company will no longer be subject to oversight by the monitor appointed under the DPA.

During the past 18 months, the Company has complied fully with the letter and spirit of the DPA and has made significant enhancements to its compliance structure and processes. The Company's enhanced corporate compliance program addresses how the Company is to interact with physician collaborators, managing potential or perceived conflicts of interest inherent in consulting relationships while preserving the best elements of collaboration that drive innovation in medical devices and services.

"While the expiration of the DPA is an important milestone, the Company remains committed to operating ethically and transparently on a global basis to preserve the trust required for productive, professional collaboration that ultimately benefits patients," said David Dvorak, Zimmer President and CEO.

The Company expects to remain subject to the terms of a Corporate Integrity Agreement it entered into with the Office of Inspector General of the Department of Health and Human Services until September 2012.

About Zimmer Holdings, Inc.

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sales were approximately $4.1 billion. The Company is supported by the efforts of approximately 8,500 employees worldwide.

For more information about Zimmer, visit

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE Zimmer Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Zimmer Holdings Names Marc Casper to Board of Directors
2. Nyer Medical Appoints Sandra Zimmerman as Chief Financial Officer
3. Zimmer Presents Trabecular Metal Technology Experience at AAOS Annual Meeting
4. Zimmer Reports Fourth Quarter and 2008 Financial Results
5. Hip Replacement Patients at Possible Risk, Cleveland Law Firm Adds Zimmer Durom Cup Lawsuit Info on
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Fourth Quarter and Full-Year 2008 Results
7. Zimmer Holdings Names Betsy Bernard to Board of Directors
8. Zimmer Holdings to Present at 27th Annual JP Morgan Healthcare Conference
9. Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive
10. Zimmer Holdings to Present at Credit Suisse 2008 Healthcare Conference
11. Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education
Post Your Comments:
(Date:10/13/2015)... PLAINSBORO, N.J. (PRWEB) , ... October 13, 2015 ... ... print media enterprise focused on cancer patients, today announced a new partnership with ... for patients battling this rare type of non-Hodgkin’s lymphoma, their families and physicians. ...
(Date:10/13/2015)... ... October 13, 2015 , ... According to an ... study has shown that women who successfully lose weight with a bariatric procedure are ... States each year. The article notes that anywhere from 40 to 50 percent of ...
(Date:10/13/2015)... ... , ... In an age where the cost of energy is rising, ... than in 2009. The Williamsport Regional Medical Center (WRMC) campus has grown 50 percent ... percent. , According to Facilities Management Administrative Director Dieter Reichmann, this is the ...
(Date:10/13/2015)... Nashville, Tenn. (PRWEB) , ... October 13, 2015 , ... ... life, and that’s why SmileCareClub , the leading remote invisible aligner system, has ... children who would otherwise go without it. For each aligner treatment plan purchased, SmileCareClub ...
(Date:10/13/2015)... , ... October 13, 2015 , ... Scientists in Seattle ... biopsy in 18 patients with or without mesothelioma. Surviving Mesothelioma has just posted an ... The doctors from PhenoPath Laboratories in Seattle and the University of British Columbia found ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... , Oct. 13, 2015 Health Gorilla ( ... Clinical Network – a secure platform for clinical data ... patients interact about and manage healthcare in the US. The ... round, for a combined total of $4.4M raised to date, ... from True Ventures , Harris Barton , ...
(Date:10/13/2015)... -- Research and Markets ( ) has announced ... Cosmetics Packaging - Market Opportunities and Forecasts, 2014 - ... --> --> The anti-counterfeit pharmaceutical ... of 15.7% during 2015-2020 --> ... for about 52% share in 2014 and would continue ...
(Date:10/12/2015)... the United States . By early next year, ... the United States . By early next year, ... The University of Texas MD Anderson Cancer Center, Elekta and ... Tesla) MRI-guided linear accelerator in the United States ... a non-clinical capacity. Royal Philips (NYSE: PHG ...
Breaking Medicine Technology: